These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7326897)

  • 1. [Nerve growth factor-like immunoreactivity in muscles of hereditary determined dystrophic mice, denervated mice and mice with cast fixations (author's transl)].
    Ohi T; Imura H; Furukawa S; Hayashi K
    Rinsho Shinkeigaku; 1981 Sep; 21(9):804-9. PubMed ID: 7326897
    [No Abstract]   [Full Text] [Related]  

  • 2. Level of nerve growth factor-like immunoreactivity in the lower limb muscles of muscular dystrophic mice.
    Furukawa S; Hayashi K; Ohi T; Imura H
    Biochem Biophys Res Commun; 1979 Sep; 90(1):130-4. PubMed ID: 496965
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of nerve growth factor (NGF) on superior cervical ganglion in dystrophic mice (author's transl)].
    Suzuki M; Nishitani H; Imura H
    Rinsho Shinkeigaku; 1981 Nov; 21(11):977-85. PubMed ID: 7333056
    [No Abstract]   [Full Text] [Related]  

  • 4. Submandibular glands in mice with muscular dystrophy: studies with nerve growth factor.
    Murphy RA; Watson AY; McCarthy M; Papastavros M; Neutra M; Forssmann WG
    Anat Rec; 1981 Jun; 200(2):177-94. PubMed ID: 7270919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve terminal contributes to acetylcholine receptor organization at the dystrophic neuromuscular junction of mdx mice.
    Marques MJ; Taniguti AP; Minatel E; Neto HS
    Anat Rec (Hoboken); 2007 Feb; 290(2):181-7. PubMed ID: 17441210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.
    Schertzer JD; Ryall JG; Lynch GS
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E499-505. PubMed ID: 16621899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical studies of dystrophic mice. Acetylcholine receptor and nerve growth factor].
    Nakao K; Imura H; Ohta M; Furukawa S; Hayashi K; Nishitani H
    Nihon Rinsho; 1977 Nov; 35(11):3943-8. PubMed ID: 599675
    [No Abstract]   [Full Text] [Related]  

  • 8. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers.
    Suh JG; Yamazaki A; Tomita T
    Lab Anim Sci; 1994 Feb; 44(1):42-6. PubMed ID: 8007658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse.
    Pastoret C; Sebille A
    Muscle Nerve; 1995 Oct; 18(10):1147-54. PubMed ID: 7659109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EDL and soleus muscles of the C57BL6J/dy2j laminin-alpha 2-deficient dystrophic mouse are not vulnerable to eccentric contractions.
    Head SI; Bakker AJ; Liangas G
    Exp Physiol; 2004 Sep; 89(5):531-9. PubMed ID: 15184359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of the nerve growth factor activity in the submaxillary glands of genetically dystrophic mouse (C57BL/6J).
    Furukawa S; Nishitani H; Hayashi K
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1202-6. PubMed ID: 901471
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of nerve section on beta-endorphin and alpha-melanotropin immunoreactivity in motor nerves of normal and dystrophic mice.
    Hughes S; Smith ME
    Neurosci Lett; 1988 Sep; 92(1):1-7. PubMed ID: 2847088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of muscular dystrophy on craniofacial growth in mice: a study of heterochrony and ontogenetic allometry.
    Lightfoot PS; German RZ
    J Morphol; 1998 Jan; 235(1):1-16. PubMed ID: 9397579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neurotrophic factor in denervated adult skeletal muscle.
    Slack JR; Pockett S
    Brain Res; 1982 Sep; 247(1):138-40. PubMed ID: 7127111
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in muscle esterases in genetically dystrophic and control littermate mice.
    Bianchi R; Paro M; Ghidotti G; Mussini E
    Muscle Nerve; 1982; 5(6):485-9. PubMed ID: 7133044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
    De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased T3 deiodination in dystrophic and neonatally denervated mouse muscle.
    De Jong JM; Van der Slooten EP; Den Hartog Jager WA
    J Neurol Sci; 1977; 31(1):83-91. PubMed ID: 833612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nondystrophic myoblast transplantation into dystrophic muscle.
    Karpati G
    Muscle Nerve; 1989 Apr; 12(4):337-9. PubMed ID: 2770785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.